Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Pyke

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The American Journal of Psychiatry|January 1, 1995
Paroxetine withdrawal syndromeR E Pyke
Archives of General Psychiatry|November 1, 1989
Depression in panic disorder and response to alprazolam therapyR E Pyke
The Journal of Clinical Psychiatry|February 1, 1988
Alprazolam in the treatment of panic attack patients with and without major depressionR E Pyke, M Kraus
Journal of Clinical Psychopharmacology|February 1, 1989
Double-blind comparison of alprazolam and adinazolam for panic and phobic disordersR E Pyke, H S Greenberg
Journal of Clinical Psychopharmacology|October 1, 1986
Norepinephrine challenges in panic patientsR E Pyke, H S Greenberg
The Journal of Clinical Psychiatry|April 1, 1988
Adinazolam mesylate and placebo in depressed outpatients: a 6-week, double-blind comparisonJ B Cohn, R E Pyke, C S Wilcox
Clinical Neuropharmacology|October 1, 1996
Analgesic efficacy of enadoline versus placebo or morphine in postsurgical painA C Pande, R E Pyke, M Greiner, et al.
Clinical Neuropharmacology|February 1, 1996
Analgesic efficacy of the kappa-receptor agonist, enadoline, in dental surgery painA C Pande, R E Pyke, M Greiner, et al.
Biological Psychiatry|January 1, 1995
The effects of central cholecystokinin receptor blockade on hypothalamic-pituitary-adrenal and symptomatic responses to overnight withdrawal from alprazolamJ L Abelson, G C Curtis, R Nesse, et al.
Biological Psychiatry|September 15, 1996
Effect of CI-988, a cholecystokinin-B receptor antagonist, on lactate-induced panicD S Cowley, J B Adams, R E Pyke, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The American Journal of Psychiatry|January 1, 1995
Paroxetine withdrawal syndromeR E Pyke
Archives of General Psychiatry|November 1, 1989
Depression in panic disorder and response to alprazolam therapyR E Pyke
The Journal of Clinical Psychiatry|February 1, 1988
Alprazolam in the treatment of panic attack patients with and without major depressionR E Pyke, M Kraus
Journal of Clinical Psychopharmacology|February 1, 1989
Double-blind comparison of alprazolam and adinazolam for panic and phobic disordersR E Pyke, H S Greenberg
Journal of Clinical Psychopharmacology|October 1, 1986
Norepinephrine challenges in panic patientsR E Pyke, H S Greenberg
The Journal of Clinical Psychiatry|April 1, 1988
Adinazolam mesylate and placebo in depressed outpatients: a 6-week, double-blind comparisonJ B Cohn, R E Pyke, C S Wilcox
Clinical Neuropharmacology|October 1, 1996
Analgesic efficacy of enadoline versus placebo or morphine in postsurgical painA C Pande, R E Pyke, M Greiner, et al.
Clinical Neuropharmacology|February 1, 1996
Analgesic efficacy of the kappa-receptor agonist, enadoline, in dental surgery painA C Pande, R E Pyke, M Greiner, et al.
Biological Psychiatry|January 1, 1995
The effects of central cholecystokinin receptor blockade on hypothalamic-pituitary-adrenal and symptomatic responses to overnight withdrawal from alprazolamJ L Abelson, G C Curtis, R Nesse, et al.
Biological Psychiatry|September 15, 1996
Effect of CI-988, a cholecystokinin-B receptor antagonist, on lactate-induced panicD S Cowley, J B Adams, R E Pyke, et al.
Pageof 2